Growth hormone treatment associates with improved circulating anti-aging protein Klotho and reduced arterial stiffness in children with CKD

Chronic kidney disease (CKD) is characterized by low levels of the anti-aging protein α-Klotho and accelerated cardiovascular (CV) morbidity. Short-term treatment with growth hormone (GH) was shown to enhance soluble Klotho (sKlotho), the circulating form of α-Klotho, and endothelial function in pat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Stabouli, Stella (VerfasserIn) , Leifheit-Nestler, Maren (VerfasserIn) , Föller, Michael (VerfasserIn) , Feger, Martina (VerfasserIn) , Bayazit, Aysun K (VerfasserIn) , Doyon, Anke (VerfasserIn) , Obrycki, Lukasz (VerfasserIn) , Ranchin, Bruno (VerfasserIn) , Oh, Jun (VerfasserIn) , Paripovic, Dusan (VerfasserIn) , Longo, Germana (VerfasserIn) , Harambat, Jerome (VerfasserIn) , Mehls, Otto (VerfasserIn) , Melk, Anette (VerfasserIn) , Querfeld, Uwe (VerfasserIn) , Schaefer, Franz (VerfasserIn) , Haffner, Dieter (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 23 July 2025
In: Clinical kidney journal
Year: 2025, Jahrgang: 18, Heft: 9, Pages: 1-12
ISSN:2048-8513
DOI:10.1093/ckj/sfaf231
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1093/ckj/sfaf231
Verlag, kostenfrei, Volltext: https://academic.oup.com/ckj/article/18/9/sfaf231/8211045?login=true
Volltext
Verfasserangaben:Stella Stabouli, Maren Leifheit-Nestler, Michael Föller, Martina Feger, Aysun K Bayazit, Anke Doyon, Lukasz Obrycki, Bruno Ranchin, Jun Oh, Dusan Paripovic, Germana Longo, Jerome Harambat, Otto Mehls, Anette Melk, Uwe Querfeld, Franz Schaefer, and Dieter Haffner, on behalf of the 4C Study Consortium and the ESPN CKD-MBD Working Group

MARC

LEADER 00000naa a2200000 c 4500
001 1961599341
003 DE-627
005 20260218201043.0
007 cr uuu---uuuuu
008 260218s2025 xx |||||o 00| ||eng c
024 7 |a 10.1093/ckj/sfaf231  |2 doi 
035 |a (DE-627)1961599341 
035 |a (DE-599)KXP1961599341 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Stabouli, Stella  |e VerfasserIn  |0 (DE-588)133993440X  |0 (DE-627)1899437487  |4 aut 
245 1 0 |a Growth hormone treatment associates with improved circulating anti-aging protein Klotho and reduced arterial stiffness in children with CKD  |c Stella Stabouli, Maren Leifheit-Nestler, Michael Föller, Martina Feger, Aysun K Bayazit, Anke Doyon, Lukasz Obrycki, Bruno Ranchin, Jun Oh, Dusan Paripovic, Germana Longo, Jerome Harambat, Otto Mehls, Anette Melk, Uwe Querfeld, Franz Schaefer, and Dieter Haffner, on behalf of the 4C Study Consortium and the ESPN CKD-MBD Working Group 
264 1 |c 23 July 2025 
300 |b Illustrationen 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 18.02.2026 
520 |a Chronic kidney disease (CKD) is characterized by low levels of the anti-aging protein α-Klotho and accelerated cardiovascular (CV) morbidity. Short-term treatment with growth hormone (GH) was shown to enhance soluble Klotho (sKlotho), the circulating form of α-Klotho, and endothelial function in patients with CKD. We hypothesized that long-term GH treatment in pediatric patients with CKD improves sKlotho levels and CV morbidity.We performed a case-cohort study within the Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study including 101 children with CKD stages 3-5 treated with and without GH. Patients were assessed for serum sKlotho, intact fibroblast growth factor 23 (iFGF23), somatomedin insulin-like growth factor 1 (IGF1), pulse wave velocity (PWV), carotid intima thickness (cIMT), and left ventricular mass index (LVMI) at two time points 12 months apart.GH-treated patients showed higher sKlotho (Δ1.2 SD) and IGF1 (Δ1.5 SD) z-scores, and lower PWV z-scores (Δ −0.9 SD) compared to controls (each P < .01), both at baseline and after 12 months of follow up. iFGF23 and cIMT z-scores, LVMI, and progression of CKD did not differ between groups. In the multivariable analysis, sKlotho z-scores associated with GH treatment, IGF1 and iFGF23 z-scores (each P < .01). PWV z-scores associated with GH treatment, diastolic blood pressure, and parathyroid hormone levels, while cIMT z-score and LVMI associated with diastolic blood pressure and hemoglobin only (each P < .05).Long-term GH treatment is associated with reduced PWV in children with CKD, which is at least partly related to GH/IGF1-induced upregulation of sKlotho. 
700 1 |a Leifheit-Nestler, Maren  |e VerfasserIn  |4 aut 
700 1 |a Föller, Michael  |e VerfasserIn  |4 aut 
700 1 |a Feger, Martina  |e VerfasserIn  |4 aut 
700 1 |a Bayazit, Aysun K  |e VerfasserIn  |4 aut 
700 1 |a Doyon, Anke  |d 1982-  |e VerfasserIn  |0 (DE-588)142072702  |0 (DE-627)633525391  |0 (DE-576)327507896  |4 aut 
700 1 |a Obrycki, Lukasz  |e VerfasserIn  |4 aut 
700 1 |a Ranchin, Bruno  |e VerfasserIn  |4 aut 
700 1 |a Oh, Jun  |e VerfasserIn  |4 aut 
700 1 |a Paripovic, Dusan  |e VerfasserIn  |4 aut 
700 1 |a Longo, Germana  |e VerfasserIn  |4 aut 
700 1 |a Harambat, Jerome  |e VerfasserIn  |4 aut 
700 1 |a Mehls, Otto  |e VerfasserIn  |0 (DE-588)1111580413  |0 (DE-627)865658137  |0 (DE-576)476191424  |4 aut 
700 1 |a Melk, Anette  |e VerfasserIn  |4 aut 
700 1 |a Querfeld, Uwe  |e VerfasserIn  |4 aut 
700 1 |a Schaefer, Franz  |d 1961-  |e VerfasserIn  |0 (DE-588)1023365383  |0 (DE-627)718365577  |0 (DE-576)366705598  |4 aut 
700 1 |a Haffner, Dieter  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Clinical kidney journal  |d Oxford : Oxford Univ. Press, 2012  |g 18(2025), 9 vom: Sept., Artikel-ID sfaf231, Seite 1-12  |h Online-Ressource  |w (DE-627)689395191  |w (DE-600)2656786-6  |w (DE-576)363260714  |x 2048-8513  |7 nnas  |a Growth hormone treatment associates with improved circulating anti-aging protein Klotho and reduced arterial stiffness in children with CKD 
773 1 8 |g volume:18  |g year:2025  |g number:9  |g month:09  |g elocationid:sfaf231  |g pages:1-12  |g extent:12  |a Growth hormone treatment associates with improved circulating anti-aging protein Klotho and reduced arterial stiffness in children with CKD 
856 4 0 |u https://doi.org/10.1093/ckj/sfaf231  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
856 4 0 |u https://academic.oup.com/ckj/article/18/9/sfaf231/8211045?login=true  |x Verlag  |z kostenfrei  |3 Volltext  |7 0 
951 |a AR 
992 |a 20260218 
993 |a Article 
994 |a 2025 
998 |g 1023365383  |a Schaefer, Franz  |m 1023365383:Schaefer, Franz  |d 910000  |d 910500  |d 50000  |e 910000PS1023365383  |e 910500PS1023365383  |e 50000PS1023365383  |k 0/910000/  |k 1/910000/910500/  |k 0/50000/  |p 16 
998 |g 1111580413  |a Mehls, Otto  |m 1111580413:Mehls, Otto  |d 910000  |d 910500  |e 910000PM1111580413  |e 910500PM1111580413  |k 0/910000/  |k 1/910000/910500/  |p 13 
998 |g 142072702  |a Doyon, Anke  |m 142072702:Doyon, Anke  |d 910000  |d 910500  |e 910000PD142072702  |e 910500PD142072702  |k 0/910000/  |k 1/910000/910500/  |p 6 
999 |a KXP-PPN1961599341  |e 4919701403 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1961599341"],"doi":["10.1093/ckj/sfaf231"]},"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"23 July 2025"}],"title":[{"title":"Growth hormone treatment associates with improved circulating anti-aging protein Klotho and reduced arterial stiffness in children with CKD","title_sort":"Growth hormone treatment associates with improved circulating anti-aging protein Klotho and reduced arterial stiffness in children with CKD"}],"person":[{"role":"aut","given":"Stella","family":"Stabouli","display":"Stabouli, Stella"},{"display":"Leifheit-Nestler, Maren","family":"Leifheit-Nestler","role":"aut","given":"Maren"},{"display":"Föller, Michael","given":"Michael","role":"aut","family":"Föller"},{"display":"Feger, Martina","role":"aut","given":"Martina","family":"Feger"},{"given":"Aysun K","role":"aut","family":"Bayazit","display":"Bayazit, Aysun K"},{"display":"Doyon, Anke","family":"Doyon","given":"Anke","role":"aut"},{"display":"Obrycki, Lukasz","role":"aut","given":"Lukasz","family":"Obrycki"},{"display":"Ranchin, Bruno","family":"Ranchin","given":"Bruno","role":"aut"},{"display":"Oh, Jun","family":"Oh","given":"Jun","role":"aut"},{"display":"Paripovic, Dusan","given":"Dusan","role":"aut","family":"Paripovic"},{"family":"Longo","given":"Germana","role":"aut","display":"Longo, Germana"},{"display":"Harambat, Jerome","family":"Harambat","given":"Jerome","role":"aut"},{"given":"Otto","role":"aut","family":"Mehls","display":"Mehls, Otto"},{"role":"aut","given":"Anette","family":"Melk","display":"Melk, Anette"},{"family":"Querfeld","role":"aut","given":"Uwe","display":"Querfeld, Uwe"},{"display":"Schaefer, Franz","role":"aut","given":"Franz","family":"Schaefer"},{"role":"aut","given":"Dieter","family":"Haffner","display":"Haffner, Dieter"}],"note":["Gesehen am 18.02.2026"],"relHost":[{"pubHistory":["5.2012 -"],"part":{"extent":"12","volume":"18","pages":"1-12","issue":"9","year":"2025","text":"18(2025), 9 vom: Sept., Artikel-ID sfaf231, Seite 1-12"},"id":{"zdb":["2656786-6"],"issn":["2048-8513"],"eki":["689395191"]},"recId":"689395191","note":["Gesehen am 27.05.2020"],"title":[{"title":"Clinical kidney journal","title_sort":"Clinical kidney journal","subtitle":"CKJ"}],"disp":"Growth hormone treatment associates with improved circulating anti-aging protein Klotho and reduced arterial stiffness in children with CKDClinical kidney journal","origin":[{"publisherPlace":"Oxford","dateIssuedKey":"2012","dateIssuedDisp":"2012-","publisher":"Oxford Univ. Press"}],"physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"titleAlt":[{"title":"Clin Kidney J"},{"title":"CKJ"}]}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1961599341","language":["eng"],"physDesc":[{"noteIll":"Illustrationen","extent":"12 S."}],"name":{"displayForm":["Stella Stabouli, Maren Leifheit-Nestler, Michael Föller, Martina Feger, Aysun K Bayazit, Anke Doyon, Lukasz Obrycki, Bruno Ranchin, Jun Oh, Dusan Paripovic, Germana Longo, Jerome Harambat, Otto Mehls, Anette Melk, Uwe Querfeld, Franz Schaefer, and Dieter Haffner, on behalf of the 4C Study Consortium and the ESPN CKD-MBD Working Group"]}} 
SRT |a STABOULISTGROWTHHORM2320